Viela Bio Patents – Insights & Stats (Updated 2025)

Viela Bio has a total of 319 patents globally, out of which 71 have been granted. Of these 319 patents, more than 91% patents are active. The United States of America is where Viela Bio has filed the maximum number of patents, followed by Korea (South) and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Viela Bio.

Viela Bio was founded in 2017. Viela Bio is a biotechnology company focused on developing treatments for severe inflammation and autoimmune diseases. Its main product, inebilizumab, is a humanized monoclonal antibody designed to target CD19, a protein found on many immune system B cells.

Do read about some of the most popular patents of Viela Bio which have been covered by us in this article and also you can find Viela Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Viela Bio patent portfolio.

How many patents does Viela Bio have?

Viela Bio has a total of 319 patents globally. These patents belong to 33 unique patent families. Out of 319 patents, 291 patents are active.

How Many Patents did Viela Bio File Every Year?

Viela Bio Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantViela Bio Applications FiledViela Bio Patents Granted
202542
2024318
20232813
2022869
2021355
20202912
2019242
201893
2017265
20161

How many Viela Bio patents are Alive/Dead?

Worldwide Patents

Viela Bio Patent Portfolio


How Many Patents did Viela Bio File in Different Countries?

Viela Bio Worldwide Patent Filing

Countries in which Viela Bio Filed Patents

CountryPatents
United States of America26
Korea (South)22
Japan21
China19
Australia18
Hong Kong (S.A.R.)18
Singapore18
Canada17
Mexico17
Brazil16
Europe (EPO)14
Israel12
Russia9
New Zealand8
Taiwan8
South Africa8
Philippines4
India3
Chile3
Indonesia3
Macao3
Hungary3
Cyprus2
Slovenia2
Estonia2
Lithuania2
Malaysia2
Slovakia2
Denmark2
Malta2
Argentina1
Africa1
Netherlands1
Luxembourg1
Spain1
Croatia1
Viet Nam1
Serbia1
Albania1
Austria1
Germany1
Portugal1
Norway1

Where are Research Centers of Viela Bio Patents Located?

R&D Centres of Viela Bio

10 Best Viela Bio Patents

US8323653B2 is the most popular patent in the Viela Bio portfolio. It has received 28 citations so far from companies like Anutra Medical, Xencor, Seismic Therapeutic.

Below is the list of 10 most cited patents of Viela Bio:

Publication NumberCitation Count
US8323653B228
RU2495882C226
WO2017156298A114
US20180273621A111
WO2021113702A17
US8883992B27
US10000553B26
WO2020069010A15
WO2022235758A14
US11072652B24

What Percentage of Viela Bio US Patent Applications were Granted?

Viela Bio (Excluding its subsidiaries) has filed 37 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 15 have been granted leading to a grant rate of 71.43%.

Below are the key stats of Viela Bio patent prosecution at the USPTO.

EA Stats of Viela Bio

Which Law Firms are managing US Patents for Viela Bio?

Law FirmTotal ApplicationsSuccess Rate
Amgen Inc (Inhouse IP Deptt)27100.00%
Cooley Llp850%
Global Patent Group20%

What are Viela Bio key innovation segments?

What Technologies are Covered by Viela Bio?

The chart below distributes patents filed by Viela Bio in different countries on the basis of the technology protected in patents. It also represents the markets where Viela Bio thinks it’s important to protect particular technological inventions.

R&D Focus: How has Viela Bio search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Viela Bio?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.